Sunshine Biopharma CFO Camille Sebaaly's 2023 pay falls 25% to $695K
Sunshine Biopharma reports 2023 executive compensation
By ExecPay News
Published: October 17, 2024
Sunshine Biopharma reported fiscal year 2023 executive compensation information on October 17, 2024.
In 2023, three executives at Sunshine Biopharma received on average a compensation package of $505K, a 15% decrease compared to previous year.
Average pay of disclosed executives at Sunshine Biopharma
Camille Sebaaly, Chief Financial Officer, received $695K in total, which decreased by 25% compared to 2022. 55% of Sebaaly's compensation, or $380K, was in bonus. Sebaaly also received $315K in salary.
Steve N. Slilaty, Chief Executive Officer, received a compensation package of $560K, which increased by 51% compared to previous year. 68% of the compensation package, or $378K, was in salary.
Abderrazzak Merzouki, Chief Operating Officer, earned $260K in 2023, a 46% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on October 17, 2024.